|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.66 USD | -8.81% |
|
-1.09% | -21.90% |
| 25/07 | Jefferies Cuts Summit Therapeutics Price Target to $15 From $17, Hold Rating Kept | MT |
| 24/07 | Summit Therapeutics Inc., Q2 2026 Earnings Call, Jul 23, 2026 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 15.93 | 17.54 | 18.89 |
| Spread/Res. | -14.25% | -22.12% | -27.69% |
| Spread/Supp. | +4.67% | +4.67% | +28.87% |
| Support | 13.05 | 13.05 | 10.6 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- SMMT Stock
- Charts Summit Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
